OCT 8, 2026 · JOURNAL ARTICLE
Biotechnological Approaches to Biofilm-Targeted Antifungal Therapy in Recurrent Vulvovaginal Candidiasis
Current Pharmaceutical Biotechnology
Abstract: Recurrent Vulvovaginal Candidiasis (RVVC) is increasing worldwide, with biofilm persistence and antifungal resistance limiting treatment options. The combined use of anti